Professor of Surgery, University Alabama
General Surgery
Dr. Marshall M. Urist, MD
|
|
Give Review
Marshall Urist works in the field of General Surgery. He went to medical school at University of Chicago Pritzker School of Medicine. University of Chicago Pritzker School of Medicine is ranked 10 in research and 19 in primary care medicine He over the years received 1 awards: "Fellow (FACS)". Marshall Urist is a published MD as well. He has 31 publications published. The latest was: Final Results of the Sunbelt Melanoma Trial: A Multi-Institutional Prospective Randomized Phase III Study Evaluating the Role of Adjuvant High-Dose Interferon Alfa-2b ... Marshall Urist accepts all Medicare patients.
Publications
- Final Results of the Sunbelt Melanoma Trial: A Multi-Institutional Prospective Randomized Phase III Study Evaluating the Role of Adjuvant High-Dose Interferon Alfa-2b ...
- DermatofibroSarcoma protuberans, version 1.2014.
- Melanoma, version 4.2014.
- What Is a Clear Margin in Breast Conserving Cancer Surgery?
- Melanoma, Version 2.2013: Featured Updates to the NCCN Guidelines.
- Diversity of stage III melanoma in the era of sentinel lymph node biopsy.
- Descriptive operative reports: teaching, learning, and milestones to safe surgery.
- The University of Alabama at Birmingham: School of Medicine and Department of Surgery.
- Surveillance after surgical treatment of melanoma: futility of routine chest radiography.
- Molecular detection of micrometastatic Breast cancer in histopathology-negative axillary lymph nodes fails to predict Breast cancer recurrence: a final analysis of a p...
- Ulceration as a predictive marker for response to adjuvant interferon therapy in melanoma.
- Pilot trial of preoperative (neoadjuvant) letrozole in combination with bevacizumab in postmenopausal women with newly diagnosed estrogen receptor- or progesterone rec...
- Basal cell and squamous cell skin Cancers.
- Prognostic information from sentinel lymph node biopsy in patients with thick melanoma.
- Second primary melanomas: incidence and outcome.
- Should all patients with melanoma between 1 and 2 mm Breslow thickness undergo sentinel lymph node biopsy?
- Factors associated with false-negative sentinel lymph node biopsy in melanoma patients.
- Board certification in surgical oncology: ABS certification is not the answer for surgical oncology.
- Factors associated with improved survival among young adult melanoma patients despite a greater incidence of sentinel lymph node metastasis.
- Preoperative radiation therapy with selective dose escalation to the margin at risk for retroperitoneal Sarcoma.
- Prospective multi-institutional study of reverse transcriptase polymerase chain reaction for molecular staging of melanoma.
- Tumor-associated down-regulation of 15-lipoxygenase-1 is reversed by celecoxib in colorectal Cancer.
- E1A-F is overexpressed early in human Colorectal neoplasia and associated with cyclooxygenase-2 and matrix metalloproteinase-7.
- Molecular detection of micrometastatic Breast cancer in histopathology-negative axillary lymph nodes correlates with traditional predictors of prognosis: an interim an...
- Treatment options for Merkel cell Carcinoma.
- Results of long-term follow-up for transanal excision for rectal Cancer.
- Axillary lymph node status, but not tumor size, predicts locoregional recurrence and overall survival after mastectomy for Breast cancer.
- Laparoscopic adrenalectomy and splenectomy are safe and reduce hospital stay and charges.
- Melanoma and sentinel nodes.
- Factors associated with local recurrence after skin-sparing mastectomy and immediate Breast reconstruction for invasive Breast cancer.
Schools
University Of ChicagoThe Pritzker School Of Medicine
Johns Hopkins
University Of California Los Angeles
Procedures Preformed
- Biopsy of Breast
- Breast Reconstruction
- Dressing and-or Debridement of Wound, Infection, or Burn (incl. Negative Pressure Wound Therapy)
- Excision of Breast Tumor
- View All
Conditions Treated
- Breast Cancer
- Breast Lump
- Carcinoma in Situ
- Colorectal Cancer
- View All
Doctors Specialties
- General Surgery
Accepted Insurances
Awards
- Fellow (FACS)
Education
-
Johns Hopkins University -
University of Chicago Pritzker School of Medicine
Hospital
-
University of Alabama Hospital
Drug Facts
| NPI NUMBER | 1982626230 | |
| NPPES Provider LastName | URIST | |
| NPPES Provider FirstName | MARSHALL | |
| NPPES Provider ZIPCode | 35233 | |
| NPPES Provider State | AL | |
| Specialty Description | Surgical Oncology | |
| Total Claim Count | 90.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 57.0 | |
| Percent Opioid Claims | 63.33 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1982626230 |
| Last Name Of The Provider | URIST |
| First Name Of The Provider | MARSHALL |
| View All |
Similar Doctors
|
|
Dr. John B. Blalock Jr., MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Timothy K. Bullock, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Brendon Haikes, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gilbert F. Douglas IV, DO
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John R. Porterfield Jr., MD |
|
|
Dr. Luis A. Gonzalez, MD |
|
|
Dr. Carol A. Leitner, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Bruce G. Lowman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Melissa L. Korb, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Beverly E. Chaignaud, MD
This Doctor is OpenDoctor Recommended.
|